Xtant Medical Holdings, Inc. Financial Ratios — XTNT Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	-158.5	- -	- -	- -	- -	- -	- -	- -	- -	-21.36	-26.09	1.54	-34.88	10.59
Return on Assets (%)	-15.44	-26.75	-40.06	-36.98	-2.57	-13.67	-41.96	-92.16	-18.36	-16.6	-10.09	-14.77	0.86	-17.64	5.29
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	9.61
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6.6
Gross Margin (%)	69.79	68.66	57.11	63.11	65.86	69.21	60.65	60.23	65.73	64.48	58.79	55.44	60.75	58.17	62.92
EBITDA Margin (%)	-18.89	-12.62	-22.75	-12.45	-7.35	1.22	-6.36	-1.11	1.38	2.49	-4.56	-9.42	-7.65	-6.69	9.34
Operating Margin (%)	-21.39	-14.99	-25.03	-15.15	-15.59	-6.83	-16.54	-10.24	-3.48	-1.41	-6.97	-11.65	-11.13	-10.3	5.44
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	116.19
Pretax Margin (%)	-9.97	-23.39	-38.38	-29.74	-33.22	-21.6	-63.44	-97.09	-12.56	-12.61	-8.77	-14.52	-1.14	-13.87	5.23
Profit Margin (%)	-9.97	-23.39	-38.38	-29.74	-3.66	-21.66	-63.44	-97.09	-12.71	-13.17	-8.77	-14.64	0.72	-14.03	3.71
Net Income to Common Margin (%)	-9.97	-23.39	-38.38	-29.74	-3.66	-21.66	-63.44	-97.09	-12.71	-13.17	-8.77	-14.64	0.72	-14.03	3.71
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	28.97
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	-158.5	- -	- -	- -	- -	- -	- -	- -	- -	-21.36	-26.09	1.54	-34.88	10.59

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	8	15	17	21	111	131	139	79	79	19	17	17	24	35	29
ST Debt	2	- -	- -	- -	- -	11	- -	- -	1	17	4	6	6	13	15
LT Debt	7	15	16	21	111	120	139	78	78	1	13	11	18	22	14
Total Debt/EBITDA	-1.47	-3.59	-2.22	-4.77	-25.37	119.08	-26.43	-97.72	88.25	13.96	-6.68	-3.13	-3.37	-4.48	2.3
Net Debt/EBITDA	-1.32	-2.31	-1.78	-3.74	-23.9	115.75	-25.7	-88.49	79.78	10.89	1.12	0.9	-2.3	-3.56	0.67
Total Debt/EBIT	-1.3	-3.02	-2.01	-3.92	-11.96	-21.28	-10.17	-10.63	-34.86	-24.69	-4.37	-2.53	-2.32	-2.91	3.94
Net Debt/EBIT	-1.17	-1.94	-1.62	-3.07	-11.27	-20.69	-9.89	-9.62	-31.52	-19.25	0.74	0.73	-1.58	-2.32	1.14
EBITDA to Interest Expense	-4.9	-2.23	-1.62	-0.78	-0.56	0.09	-0.36	-0.08	0.15	0.22	-2.53	-3.23	-2.38	-1.89	3.41
EBITDA-CapEx/Interest Expense	-5.84	-3.22	-1.78	-0.88	-10.29	-0.86	-0.58	-0.14	- -	-0.04	-4.66	-4.27	-2.87	-2.88	2.76
EBIT to Interest Expense	-5.55	-2.65	-1.78	-0.95	-1.2	-0.5	-0.93	-0.73	-0.39	-0.13	-3.87	-3.99	-3.46	-2.9	1.98
Interest Expense	1	2	5	6	8	12	15	10	6	6	1	2	3	4	4
Common Equity/Total Assets	23.74	12.27	-13.31	-27.82	6.29	-4.91	-55.53	-94.29	-102.43	35	56.47	56.74	55.45	45.78	54.12
Long-Term Debt/Equity (%)	122.3	348	- -	- -	1,246.84	- -	- -	- -	- -	8.98	41.23	31.72	35.14	51.79	26.89
Long-Term Debt/Capital (%)	48.42	76.89	128.22	157.96	92.55	97.07	172.69	224.57	227.09	3.94	26.68	21.15	24.09	28.49	17.2
Long-Term Debt/Total Assets (%)	29.04	42.7	57	74.71	78.48	83.31	131.11	168.33	180.67	3.14	23.28	18	19.48	23.71	14.56
Total Debt/Equity (%)	152.6	352.61	-434.09	-270.03	1,247.24	-1,848.46	-236.72	-179.5	-177.67	127.76	54.54	49.96	45.88	81.8	56.36
Total Debt/Capital (%)	60.41	77.91	129.93	158.81	92.58	105.72	173.14	225.79	228.75	56.09	35.29	33.32	31.45	44.99	36.04
Total Debt/Total Assets (%)	36.23	43.26	57.76	75.11	78.5	90.73	131.45	169.25	182	44.72	30.8	28.35	25.44	37.45	30.5
Net Debt to Equity	136.7	226.87	-348.41	-211.61	1,175.01	-1,796.78	-230.17	-162.53	-160.63	99.6	-9.18	-14.34	31.3	65.08	16.35
Net Debt/Capital (%)	57.21	67.48	136.74	188	92.12	104.95	174.56	254.08	244.03	47.06	-9.62	-15.83	23.23	38.88	13.3
EBITDA	-6	-4	-8	-4	-4	1	-5	-1	1	1	-3	-5	-7	-8	13
EBITDA-CapEx	-7	-6	-8	-5	-80	-11	-9	-1	- -	- -	-5	-7	-8	-12	10
Operating Income (Loss)	-6	-5	-8	-5	-9	-6	-14	-7	-2	-1	-4	-7	-10	-12	7

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.07	0.57	0.32	0.53	0.3	0.08	0.11	0.56	0.56	0.09	1.65	1.33	0.25	0.22	0.58
Current Ratio	1.52	2.94	1.99	2.25	2.1	1.57	1.54	2.88	3.43	1.22	4	3.24	2.82	2.35	2.65
Quick Ratio	0.72	1.39	0.81	1.05	1.01	0.69	0.6	1.39	1.64	0.36	2.29	2.05	1.15	0.94	1.54
CFO/Avg Current Liab	-0.59	-1.1	-0.53	-0.81	-0.61	-0.55	-0.02	0.06	-0.04	-0.04	0.02	-0.41	-0.5	-0.46	0.43
Common Equity/Total Assets	23.74	12.27	-13.31	-27.82	6.29	-4.91	-55.53	-94.29	-102.43	35	56.47	56.74	55.45	45.78	54.12
Long-Term Debt/Equity (%)	122.3	348	- -	- -	1,246.84	- -	- -	- -	- -	8.98	41.23	31.72	35.14	51.79	26.89
Long-Term Debt/Capital (%)	48.42	76.89	128.22	157.96	92.55	97.07	172.69	224.57	227.09	3.94	26.68	21.15	24.09	28.49	17.2
Long-Term Debt/Total Assets (%)	29.04	42.7	57	74.71	78.48	83.31	131.11	168.33	180.67	3.14	23.28	18	19.48	23.71	14.56
Total Debt/Equity (%)	152.6	352.61	-434.09	-270.03	1,247.24	-1,848.46	-236.72	-179.5	-177.67	127.76	54.54	49.96	45.88	81.8	56.36
Total Debt/Capital (%)	60.41	77.91	129.93	158.81	92.58	105.72	173.14	225.79	228.75	56.09	35.29	33.32	31.45	44.99	36.04
Total Debt/Total Assets (%)	36.23	43.26	57.76	75.11	78.5	90.73	131.45	169.25	182	44.72	30.8	28.35	25.44	37.45	30.5
CFO/Total Liabilities	-41.67	-35.66	-14.95	-20.5	-6.89	-9.53	-0.33	1.34	-0.47	-2.71	1.84	-20.5	-23.06	-23.38	29.05
CFO/CapEx	-6.69	-5.88	-6.41	-12.21	-0.12	-1.24	-0.17	1.94	-0.47	-0.47	0.21	-3.03	-6.54	-2.89	5.27
Altman's Z-Score	2.51	0.27	-1.84	-2.15	-0.6	-0.54	-2.92	-5.16	-5.63	-4.94	-3.6	-3.01	-0.95	-2.34	-0.07

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	5.69	4.63	5.54	7.66	5.99	5.24	5.21	6.36	6.43	6.27	7.88	6.44	5.78	5.67	6.96
Days Sales Outstanding	64.2	78.79	65.93	47.63	60.93	69.71	70.04	57.39	56.75	58.18	46.35	56.69	63.13	64.42	52.41
Inventory Turnover	1.31	0.96	1.19	1.28	1.26	1.13	1.34	1.45	1.33	1.01	1.16	1.47	1.32	1.3	1.44
Days Inventory Outstanding	278.89	381.71	307.41	284.4	290.41	322.4	273.32	252.45	275.01	361.33	315.37	248.9	275.87	280.98	253.23
Accounts Payable Turnover	4.94	4.51	3.49	3.56	5.03	3.15	2.9	2.99	4.85	9.45	6.94	8.25	10.52	6.79	7.02
Accounts Payable Turnover Days	73.83	80.94	104.65	102.42	72.5	115.82	125.97	122.06	75.32	38.64	52.57	44.26	34.71	53.79	52
Cash Conversion Cycle	269.26	379.56	268.69	229.61	278.84	276.28	217.39	187.78	256.44	380.87	309.15	261.32	304.29	291.61	253.64
Inventory to Cash Days	-214.69	-302.93	-241.48	-236.77	-229.48	-252.69	-203.28	-195.06	-218.26	-303.15	-269.02	-192.21	-212.74	-216.56	-200.81
Inventories	8	13	11	10	23	26	22	17	16	21	18	17	37	39	30
Raw Materials	2	2	3	4	5	5	4	4	3	4	6	6	7	7	6
Work In Process	3	5	3	2	3	2	2	1	1	2	1	1	2	3	5
Finished Goods	5	7	6	5	18	24	24	25	11	16	12	11	28	29	20
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	11	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	128	59	29	22	37	10	10	21	21	93	49	72	147	62	110
- Cash & Cash Equivalents	1	5	3	4	6	3	3	7	5	2	18	20	6	6	17
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	8	15	17	21	111	131	139	79	79	19	17	17	24	35	29
Enterprise Value	136	69	43	39	141	138	147	93	95	109	47	69	165	91	121
Total Capital	14	19	13	13	120	124	80	35	34	33	48	51	75	78	80
Total Debt/Capital (%)	60.41	77.91	129.93	158.81	92.58	105.72	173.14	225.79	228.75	56.09	35.29	33.32	31.45	44.99	36.04
Total Debt / EV	0.06	0.22	0.39	0.54	0.79	0.95	0.95	0.84	0.83	0.17	0.36	0.25	0.14	0.39	0.24
EV/Sales	4.51	2.09	1.3	1.1	2.38	1.53	1.77	1.29	1.46	2.04	0.86	1.18	1.81	0.77	0.91
EV/EBITDA	172.24	87.28	52.77	38.18	27.04	125.44	17.43	13.78	106.2	82.07	34.88	45.57	48.02	20.87	9.71
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	16.67
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	10.35	8.2	17.41	19.79	33.03	- -	- -	- -	8.01
EV/Free Cash Flow to Firm	- -	- -	82	- -	2.1	14.44	8.42	7.77	14.98	15.45	13.34	- -	- -	- -	6.93
Diluted Market Cap	122	58	26	20	28	7	10	19	21	34	48	62	143	59	118
Diluted Enterprise Value	130	68	40	36	132	135	147	91	95	50	46	59	161	88	129
EV per Share	363.63	175.45	87.85	63.36	129.32	95.07	96.01	7.02	7.13	1.4	0.54	0.63	1.27	0.65	0.87
TTM Sales	30	33	33	35	59	90	83	72	65	53	55	58	91	117	134
TTM EBITDA	-6	-4	-8	-4	-4	1	-5	-1	1	1	-3	-5	-7	-8	13
TTM Operating Income	-6	-5	-8	-5	-9	-6	-14	-7	-2	-1	-4	-7	-10	-12	7
TTM Cash Flow to Firm	-6	-9	- -	-2	-8	-2	14	11	5	6	1	-4	-11	-8	15
TTM Free Cash Flow to Firm	-5	-7	1	-1	67	10	17	12	6	7	4	-2	-10	-4	18

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-19.56	-6.51	-6.33	-2.95	0.42	-2.55	3.86	10.37	45.53	41.88	18.74	-17.36	-17.78	-7.61	7.88
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	16.67
Enterprise Value	136	69	43	39	141	138	147	93	95	109	47	69	165	91	121
Low Price	193.2	112.8	44.4	26.28	27.36	5.43	3.42	1.61	1.42	0.55	0.56	0.43	0.56	0.33	0.34
EV/Sales	4.51	2.09	1.3	1.1	2.38	1.53	1.77	1.29	1.46	2.04	0.86	1.18	1.81	0.77	0.91
EV/EBITDA	172.24	87.28	52.77	38.18	27.04	125.44	17.43	13.78	106.2	82.07	34.88	45.57	48.02	20.87	9.71
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	203.9	- -	22
Price/Earnings Average	-47.13	-11.12	-3.02	-3.52	-15.76	-1.15	-0.21	-0.92	-4.35	-4.47	-26.98	-6.78	164.81	-6.14	17.25
Price/Earnings High	-128.18	-21.42	-6.09	-8.78	-20.61	-2.46	-0.42	-1.94	-7.66	-14.2	-115.96	-10.22	261.65	-10.65	26.65
Price/Earnings Low	-22.93	-5.69	-1.52	-1.36	-10.44	-0.3	-0.1	-0.27	-2.29	-2.23	-9.87	-4.76	101.05	-2.69	9.54
Price/Book Value	23.35	13.92	-7.65	-2.86	4.13	-1.35	-0.18	-0.49	-0.48	6.39	1.58	2.1	2.86	1.43	2.15
Price/Book Value Average	27.01	20.48	-11.2	-5.34	5.07	-4.32	-0.19	-1.65	-0.81	5.88	4.32	1.95	2.32	2.45	1.69
Price/Book Value High	73.47	39.43	-22.63	-13.32	6.63	-9.22	-0.38	-3.49	-1.42	18.71	18.55	2.94	3.68	4.24	2.61
Price/Book Value Low	13.14	10.47	-5.66	-2.07	3.36	-1.11	-0.09	-0.49	-0.43	2.94	1.58	1.37	1.42	1.07	0.93
Price/Tangible Book Value	31.2	20.24	-6.63	-2.64	-0.5	-0.11	-0.09	-0.45	-0.44	8.55	1.79	2.35	4.33	2.26	2.46
Price/Tangible Book Value Average	36.1	29.77	-9.71	-4.92	-0.62	-0.36	-0.1	-1.52	-0.75	7.87	4.89	2.17	3.5	3.85	1.93
Price/Tangible Book Value High	98.18	57.32	-19.63	-12.28	-0.81	-0.77	-0.19	-3.21	-1.31	25.02	21	3.28	5.56	6.67	2.98
Price/Tangible Book Value Low	17.56	15.22	-4.91	-1.91	-0.41	-0.09	-0.05	-0.45	-0.39	3.93	1.79	1.53	2.15	1.69	1.07
Price/Sales	4.06	1.77	0.79	0.56	0.47	0.08	0.13	0.26	0.33	0.64	0.87	1.07	1.47	0.5	0.82
Price/Sales Average	4.7	2.6	1.16	1.05	0.58	0.25	0.14	0.89	0.55	0.59	2.37	0.99	1.19	0.86	0.64
Price/Sales High	12.78	5.01	2.34	2.61	0.75	0.53	0.27	1.88	0.97	1.87	10.18	1.5	1.89	1.49	0.99
Price/Sales Low	2.29	1.33	0.58	0.41	0.38	0.06	0.06	0.26	0.29	0.29	0.87	0.7	0.73	0.38	0.35
Price/Cash Flow	-16.63	-5.41	-5.34	-2.71	-3.06	-0.49	-19.22	15.71	-51.37	-46.63	109.01	-11.63	-14.14	-4.98	8.72
Price/Cash Flow Average	-19.25	-7.95	-7.82	-5.05	-3.77	-1.56	-20.73	53.09	-86.62	-42.91	298.05	-10.77	-11.43	-8.49	6.84
Price/Cash Flow High	-52.35	-15.31	-15.81	-12.6	-4.92	-3.32	-40.61	112.22	-152.51	-136.46	1,280.87	-16.24	-18.15	-14.72	10.57
Price/Cash Flow Low	-9.36	-4.06	-3.95	-1.96	-2.49	-0.4	-9.57	15.71	-45.59	-21.44	109.01	-7.56	-7.01	-3.72	3.78
Price/Free Cash Flow Average	-22.63	-9.58	-9.27	-5.5	0.52	-8.14	4.16	35.05	76.77	38.54	51.23	-16.08	-14.37	-12.98	6.18
Price/Free Cash Flow High	-61.54	-18.45	-18.73	-13.73	0.68	-17.36	8.15	74.08	135.16	122.54	220.17	-24.25	-22.81	-22.5	9.55
Price/Free Cash Flow Low	-11.01	-4.9	-4.68	-2.13	0.34	-2.1	1.92	10.37	40.41	19.26	18.74	-11.29	-8.81	-5.68	3.42
EV/Sales Average	5.18	2.93	1.71	1.64	2.52	1.76	1.78	1.99	1.69	1.9	2.39	1.09	1.5	1.14	0.73
EV/Sales High	13.66	5.36	3.04	3.4	2.75	2.15	1.92	3.11	2.11	5.39	10.34	1.68	2.26	1.8	1.08
EV/Sales Low	2.65	1.65	1.07	0.92	2.26	1.51	1.71	1.29	1.42	1.1	0.86	0.75	0.99	0.64	0.44
EV/EBITDA Average	-27.43	-23.23	-7.53	-13.18	-34.23	144.58	-28.04	-179.06	122.55	76.5	-52.31	-11.6	-19.58	-17.07	7.82
EV/EBITDA High	-72.31	-42.5	-13.37	-27.29	-37.4	176.11	-30.1	-279.06	153.12	216.65	-226.61	-17.78	-29.58	-26.89	11.57
EV/EBITDA Low	-14.04	-13.05	-4.7	-7.41	-30.74	123.9	-26.88	-115.84	103.52	44.33	-18.78	-7.96	-12.99	-9.55	4.74
EV/EBIT Average	-24.22	-19.55	-6.84	-10.84	-16.14	-25.84	-10.79	-19.47	-48.41	-135.27	-34.23	-9.38	-13.46	-11.1	13.42
EV/EBIT High	-63.84	-35.77	-12.15	-22.44	-17.64	-31.47	-11.58	-30.34	-60.49	-383.1	-148.29	-14.38	-20.34	-17.48	19.87
EV/EBIT Low	-12.39	-10.98	-4.27	-6.09	-14.5	-22.14	-10.34	-12.6	-40.89	-78.39	-12.29	-6.44	-8.93	-6.21	8.14
Last Price	343.2	150	60	36.36	33.6	6.6	6.87	1.61	1.6	1.2	0.56	0.66	1.13	0.44	0.78
High Price	1,080	424.8	177.6	169.2	54	45	14.52	11.5	4.75	3.5	6.58	0.92	1.45	1.31	0.95
Enterprise Value Average	156	97	57	58	149	159	147	144	109	102	132	63	137	134	98
Enterprise Value High	412	177	101	120	163	193	158	224	136	288	572	97	207	211	145
Enterprise Value Low	80	54	35	33	134	136	141	93	92	59	47	43	91	75	59

Shares Outstanding	- -	- -	- -	1	1	1	2	13	13	78	87	109	130	139	140
Diluted Weighted Avg Shares	- -	- -	- -	1	1	1	2	12	13	28	85	94	127	134	150
Basic Weighted Avg Shares	- -	- -	- -	1	1	1	2	12	13	28	85	94	119	134	140
Revenue per Share	84.49	84.8	75.94	64.76	71.53	84.57	54.39	6.11	4.88	1.87	0.65	0.62	0.77	0.88	0.96
EBITDA per Share	-15.96	-10.7	-17.28	-8.06	-5.26	1.03	-3.46	-0.07	0.07	0.05	-0.03	-0.06	-0.06	-0.06	0.09
Operating Income per Share	-18.08	-12.71	-19.01	-9.81	-11.15	-5.77	-9	-0.63	-0.17	-0.03	-0.05	-0.07	-0.09	-0.09	0.05
Basic EPS, GAAP	-8.43	-19.83	-29.15	-19.26	-2.62	-18.32	-34.51	-5.93	-0.62	-0.25	-0.06	-0.09	0.01	-0.12	0.04
Basic EPS from Cont Ops	-8.43	-19.83	-29.15	-19.26	-2.62	-18.32	-34.51	-5.93	-0.62	-0.25	-0.06	-0.09	0.01	-0.12	0.04
Diluted EPS, GAAP	-8.43	-19.83	-29.15	-19.26	-2.62	-18.32	-34.51	-5.93	-0.62	-0.25	-0.06	-0.09	0.01	-0.12	0.03
Diluted EPS from Cont Ops	-8.43	-19.83	-29.15	-19.26	-2.62	-18.32	-34.51	-5.93	-0.62	-0.25	-0.06	-0.09	0.01	-0.12	0.03
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-20.63	-27.75	-11.23	-13.43	-10.97	-13.54	-0.36	0.1	-0.03	-0.03	0.01	-0.06	-0.08	-0.09	0.09
Free Cash Flow per Basic Share	-23.71	-32.47	-12.99	-14.52	-101.65	-24.48	-2.5	0.05	-0.1	-0.08	-0.02	-0.08	-0.09	-0.12	0.07
Cash & Equivalents per Share	2.01	12.54	6.22	7.3	5.84	1.78	1.87	0.51	0.4	0.03	0.21	0.19	0.04	0.04	0.12
Book Value per Share	14.7	10.77	-7.85	-12.7	8.14	-4.88	-38.45	-3.3	-3.33	0.19	0.35	0.31	0.39	0.31	0.36
Tangible Book Value per Share	11	7.41	-9.05	-13.77	-66.87	-58.36	-74.7	-3.58	-3.61	0.14	0.31	0.28	0.26	0.2	0.32

Xtant Medical Holdings, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)